When it comes to outcomes, medication choices and patient adherence are some of the biggest variables that determine success. Impacting the prescription process means overcoming hurdles in operations, technology and EHR UX. Commercializing such a product in multiple countries- that’s a whole different challenge. That’s why Synapse Medicine and CEO Dr. Clement Goehrs have such an impressive story. Synapse has found fit in both Europe and the United States with their innovative approach to prescriptions across the care journey. In this episode of Diagnosing Healthtech, we talk with Dr. Clement Goehrs about the current state of clinical decision support, AI and his journey building Synapse Medicine.
Related Posts
Achieving inclusive real-world data and enabling access to care with Reagan-Udall’s Susan Winckler & Carla Rodriguez-Watson on Diagnosing Healthtech
https://www.youtube.com/watch?v=rD44LBgfl98 No matter how much health data you collect, it’s only valuable if it’s inclusive of entire affected…
